A detailed history of Dme Capital Management, LP transactions in Viatris Inc stock. As of the latest transaction made, Dme Capital Management, LP holds 7,399,810 shares of VTRS stock, worth $84.7 Million. This represents 3.85% of its overall portfolio holdings.

Number of Shares
7,399,810
Previous 4,517,620 63.8%
Holding current value
$84.7 Million
Previous $53.9 Billion 45.83%
% of portfolio
3.85%
Previous 2.47%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $29 Million - $34.6 Million
2,882,190 Added 63.8%
7,399,810 $78.7 Billion
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $50.9 Million - $61.1 Million
4,517,620 New
4,517,620 $53.9 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Dme Capital Management, LP Portfolio

Follow Dme Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dme Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dme Capital Management, LP with notifications on news.